Jefferies analyst Ed Mundy maintained a Buy rating on Coca-Cola Europacific Partners (CCEP – Research Report) yesterday and set a price target of €77.00. The company’s shares closed last Friday at $65.94.
Mundy covers the Consumer Defensive sector, focusing on stocks such as Diageo, Coca-Cola Europacific Partners, and Fevertree Drinks. According to TipRanks, Mundy has an average return of 4.9% and a 53.09% success rate on recommended stocks.
Currently, the analyst consensus on Coca-Cola Europacific Partners is a Strong Buy with an average price target of $70.36.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $66.23 and a one-year low of $51.87. Currently, Coca-Cola Europacific Partners has an average volume of 2.03M.
Based on the recent corporate insider activity of 98 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CCEP in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Coca-Cola Europacific Partners (CCEP) Company Description:
Coca-Cola European Partners Plc engages in the distribution and sale of ready-to-drink beverages. It operates through the following brands: Coca-Cola, Diet Coke or Coca-Cola Light, Coke Zero, Coca-Cola Life, Fanta, and Sprite. It also offers energy drinks, waters, juices, sports drinks, and ready-to-drink teas. The company was founded on August 4, 2015 and is headquartered in Uxbridge, the United Kingdom.
Read More on CCEP:
- Nasdaq announces annual changes to Nasdaq-100 Index
- Coca-Cola Europacific Partners assumed with a Buy at UBS
- Coca-Cola Europacific Partners upgraded to Buy from Neutral at Goldman Sachs
- Coca-Cola Europacific Partners price target raised to EUR 70 at JPMorgan
- Coca-Cola Europacific Partners price target raised to $77 from $72.50 at JPMorgan
